Skip to main content
Pathogens logoLink to Pathogens
. 2024 Jun 24;13(7):531. doi: 10.3390/pathogens13070531

Prevalence of Subgingival Aggregatibacter actinomycetemcomitans: Descriptive Cross-Sectional Study

Nabil Khzam 1,2, Omar Kujan 1,*, Dorte Haubek 3, Aysen Arslan 4, Anders Johansson 4, Jan Oscarsson 4, Zeinab Razooqi 4, Leticia Algarves Miranda 1
Editors: Milena Radunovic, Natalia Di Pietro
PMCID: PMC11279484  PMID: 39057758

Abstract

This paper aims to investigate the presence of Aggregatibacter actinomycetemcomitans and to assess potential indicators of the risk of severe form(s) of periodontitis. A descriptive cross-sectional study of 156 consecutive patients with periodontitis was conducted. Subgingival plaque samples were collected from the participants. The identification of A. actinomycetemcomitans was performed using quantitative polymerase chain reaction. A descriptive analysis, a chi-square test, and a binary logistic regression statistical evaluation were performed. The prevalence of A. actinomycetemcomitans in this population of 156 participants was 17.30% (27 patients). The prevalence of stage-III periodontitis was 75.6% and greater in older men, while the prevalence of stage-IV periodontitis was 22.4% and greater in younger women. We observed a significant relation between the risk of severe periodontitis (stage-IV) and poor oral hygiene (p = 0.006), attendance at dental appointments (p ≤ 0.001), and familial history of periodontitis (p = 0.032). In conclusion, twenty-seven individuals were positive for A. actinomycetemcomitans. Poor oral hygiene, family history of periodontitis, and irregular attendance at dental appointments were identified as potential risk factors for severe periodontitis in this cohort.

Keywords: A. actinomycetemcomitans, periodontitis, severity, new classification, extent, prevalence

1. Introduction

Periodontitis is a multifactorial oral disease; it affects the attachment apparatus that surrounds and supports the teeth. In addition, periodontitis is associated with chronic illnesses, such as diabetes mellitus, cardiovascular diseases, bone-related diseases, and others [1]. It is extremely important to understand the relationship between oral health and disease, as this clearly pinpoints the underlining genetics, microbial diversity, and functional activity. The oral microbiome is constantly under pressure from external insults and foreign substances, which could disrupt the balance between the microbial challenge and the host immune response, leading to disease [2]. There is evidence implicating A. actinomycetemcomitans as one of the key pathogens in periodontitis [3]. This sophisticated opportunistic pathogen of humans that is present in the oral cavity can destroy human leukocytes through the expression of exotoxins, leukotoxin LtxA, and the cytolethal distending toxin (Cdt) [4,5]. There are multiple lines of evidence that implicates A. actinomycetemcomitans in oral and systemic disease. Clinical, microbiological, genetics, and experimental data link the initiation, progression, and recurrence of periodontitis to A. actinomycetemcomitans [6,7]. Furthermore, A. actinomycetemcomitans has a critical role in the diagnosis and vaccination process in periodontitis [8,9]. The percentage of patients carrying A. actinomycetemcomitans and its strains seems to vary significantly between populations in various geographic areas worldwide and between ethnic groups [10]. It has been shown in subgingival samples from 1449 Swedish periodontitis patients that age is an important parameter for the prevalence of A. actinomycetemcomitans [11]. The prevalence and proportion of this bacterium was higher in young patients compared with that in older patients. Another study that compared periodontitis patients in Spain and the Netherlands found a difference in A. actinomycetemcomitans presence (23% versus 3%) [12]. The presence of A. actinomycetemcomitans has not been reported before in the Western Australian population.

In 2018, the ‘World of Periodontology’ came together from both sides of the Atlantic to propose a new classification of periodontal and peri-implant diseases and conditions [13]. However, there are hardly any epidemiological studies that adopted the data that this classification contains. Using the new classification in a future study is very important in establishing a unified diagnosis and treatment pathways of periodontitis.

The national survey of adult oral health of Australians was conducted between 2004 and 2006, in which 14,123 people aged 15–97 years old were interviewed and 5505 people were dentally examined. One in five Australian adults had moderate (20.5% of people) or severe (2.4% of people) periodontitis [14]. The case definition followed that in Beck‘s study [15]. The national study of adult oral health in Australia was published in 2019 [16]. In both Australian surveys, periodontitis was strongly associated with age, males, less schooling, lack of dental insurance, those eligible for public dental care, and people who visited the dentist for treatment of urgent dental problems.

This study aimed to investigate the carrier rate of the periodontal pathogen A. actinomycetemcomitans in subgingival dental plaque in a periodontitis cohort of Western Australians using quantitative real-time polymerase chain reaction (qPCR). The secondary aim was to assess potential indicators of the risk of severe form(s) of periodontitis in this group.

2. Methods

2.1. Research Subjects

A descriptive cross-sectional study was conducted on 156 consecutive patients with periodontitis, aged 18 years and older, who were recruited from two private periodontal practices in Perth city, Western Australia, between June and November 2022 to take part in the present study.

To be included in this study, the participants had to be from Western Australia, be 18 years and older, and not be taking any medication known to affect the periodontal tissue (antibiotics, host modulation agents, and pain killers). Participants were excluded from the study if they had any of the following within 3 months’ time of starting this study: teeth scaling, course of antibiotics, periodontal treatment, and acute periodontal infection. The patients answered a questionnaire about their biodata (age, gender, origin, level of education, residence, occupation, marital status, oral hygiene practice, last dental visit, para-functional habit(s), family history of periodontitis, smoking status, dental anxiety, and overall health).

2.2. Clinical Examination

Periodontal and radiographic examinations were carried out by one experienced periodontist (N.K.). In each patient, the examination included measurement and scoring of a series of different parameters characterizing periodontitis. All surfaces of all teeth available (except wisdom teeth) were examined using an automated Florida probe system (Florida Probe Corporation, Gainesville, FL, USA). An orthopantomogram (OPG) was used to calculate the radiographic data. The Veraview X800 software program (J. MORITA MFG. CORP. Kyoto, Japan) was used to measure the bone loss in millimetres (bone loss amount in percentage of the root length) [13]. The collected periodontal clinical data included bleeding upon probing (BoP) [17], suppuration (present/absent), number of missing teeth, reason for tooth loss (periodontal/non-periodontal), plaque index (PI) [17], bone loss/age [13], bone loss [13], vertical bone loss (present/absent), periodontal pocket depth (PD) measured as the distance in millimetres from the free gingival margin to the bottom of the pocket, gingival recession measured as the distance from the cementoenamel junction to the free gingival margin, and clinical attachment loss (CAL). Three categories of PD and CAL were recorded [13].

2.3. Case Definition of Periodontitis

Cases with periodontitis were defined according to the 2018 classification of periodontal and peri-implant diseases and conditions [13].

2.4. Subgingival Plaque Sample Collection

In each patient, subgingival plaque samples were collected. The pooled subgingival plaque samples were collected using a sterile universal mini-curette. For each patient, subgingival plaque samples were collected from four diseased and four healthy sites (two samples per quadrant). The total number of samples collected was 1248 subgingival plaque samples; these samples were pooled into 156 samples (one sample per patient). The subgingival plaque samples were collected in sterile ice-chilled 5.0 mL Eppendorf tubes (Eppendorf South Pacific Pty, Ltd., Macquarie Park, NSW, Australia). A courier with specialized freezing equipment was used for the transportation of the coded subgingival plaque samples; all samples were sent from NK Periodontics practices in Western Australia to the Dental School, Department of Odontology, Umeå University, Sweden, for subsequent processing and analysis.

2.5. Bacterial DNA Extraction

For DNA isolation from the plaque samples, a GXT NA Extraction Kit® (Hain Lifescience, GmBH, Nehren, Germany) and an Arrow automated extraction instrument (Liaison IXT, DiaSorin Ltd., Fort Henry, Ireland) were used, following the procedures described earlier [18].

2.6. DNA Quantification

The amount of total extracted DNA in each plaque sample was quantified using a NanoDrop (Thermo Fisher, Waltham, MA, USA) instrument. For quantification of A. actinomycetemcomitans loads, suspensions of the reference strain HK1651 were treated as described and used for standard curves, i.e., by being serially diluted [18].

A Corbett Research Rotor-Gene 6000 Rotary Analyze instrument (QIAGEN, Valencia, CA, USA) was used for the quantification of the total concentration of A. actinomycetemcomitans loads in the samples, using qPCR. The cycling conditions used were according to the Kirakodu method [19]. The oligonucleotide primers used were as follows: forward 5′-CTAGGTATTGCGAAACAATTTG-3′ and reverse 5′-CCTGAAATTAAGCTGGTAATC-3′. A load of 100 A. actinomycetemcomitans cells per ml of sample was set as a positive result regarding the presence of this bacterium. The DNA concentration of A. actinomycetemcomitans in each sample was determined from duplicates. All laboratory work was carried out by an experience team at Umeå University (A.A., J.O., and Z.R.).

2.7. Measurement Reliability of the Examiner and Reproducibility

To determine the intra-examiner consistency, the principal investigator (N.K.) re-examined ten patients twice, fourteen days a part. A Kappa value of 0.87 was obtained for PD measurements in this study, with a score of ≤0.4 being considered poor to fair agreement, 0.41–0.60 being moderate agreement, 0.61–0.80 being substantial agreement, and 0.8–1.00 being excellent agreement.

2.8. Statistical Analysis

The collected data were analysed using IBM SPSS Statistics software program version 29.0 (SPSS Inc., Chicago, IL, USA). The primary outcomes were the presence of A. actinomycetemcomitans and the severity of periodontitis. A descriptive analysis was performed, evaluating the quantitative and qualitative variables, and presented in tables. Furthermore, a chi-square test was carried out to evaluate the relationships between gender, level of education, marital status, oral hygiene methods, dental visits, smoking, and occupation. More analyses were conducted to evaluate the relationships between different levels of periodontitis; A. actinomycetemcomitans presence; and other potential risk factors like age, gender, overall health, oral hygiene methods, frequency of dental visits, marital status, and smoking status. The confidence level was set at 95%. To assess the risk of an advanced form of periodontitis with the presence of the different potential risk factors evaluated, the methodology of binary logistic regression was used. The significance level used was 5%.

The sample size of the present study was calculated by averaging the prevalence of A. actinomycetemcomitans from studies of similar cohorts. We estimated the average prevalence of the present study to be around 10% in order to achieve a 95% confidence interval with 5% precision; thus, we required a sample size of at least 139 participants.

2.9. Ethical Considerations

Those who agreed to participate in this study signed an informed consent form. All patients’ data were entered into a cloud-based software program using coded numbers to protect their privacy. Approval to conduct the current study was given by the Human Ethics, Office of Research at The University of Western Australia (2022/ET000252).

3. Results

3.1. Levels of A. Actinomycetemcomitans

A. actinomycetemcomitans was present in 27 (17.30%) of the participants, and their levels of this bacterium in the analysed samples are presented in Table 1, which also demonstrates additional characteristics of the A. actinomycetemcomitans-positive patients. Table 2 shows an association between the detection of A. actinomycetemcomitans and the other variables. The mean DNA concentration of A. actinomycetemcomitans was 106.11 ng/μL (SD ± 20.06) in A. actinomycetemcomitans-positive patients (n = 27) compared to 8.50 ng/μL (SD ± 16.55) in the A. actinomycetemcomitans-negative patients (n = 129).

Table 1.

A. actinomycetemcomitans-positive patients and their characteristics.

Pt/Variable Sex Age/Years Origin Stage/Grade Status of Health Aa Levels ng/μL Status
Pt 1 F 70 Philippines III/B - 848,041 M
Pt 2 M 48 Australia IV/C - 22,379 M
Pt 3 F 48 Australia III/B - 10,401 M
Pt 4 M 40 New Zealand (Māori) IV/C S 1719 M
Pt 5 M 49 New Zealand (Māori) III/B - 1680 M
Pt 6 F 56 Thailand III/B DM-II 1448 M
Pt 7 M 54 New Zealand (Māori) III/B - 303 M
Pt 8 M 68 Australia IV/C - 365,681 M
Pt 9 M 34 Tonga IV/C DM-II 851 M
Pt 10 F 56 UK III/B - 153 M
Pt 11 F 65 New Zealand (Māori) IV/C - 10,651 S
Pt 12 F 40 Australia III/B - 577 M
Pt 13 M 39 United Kingdom III/B - 153 S
Pt 14 F 62 Kenya III/B - 381,842 M
Pt 15 F 36 Australia III/B - 4624 M
Pt 16 M 40 Australia III/B - 340 S
Pt 17 M 57 Samoa III/B S 56,334 M
Pt 18 F 47 Palestine III/B - 46,227 M
Pt 19 M 40 Australia III/B - 184,822 S
Pt 20 M 75 Italy III/B - 132 M
Pt 21 M 56 South African III/B - 479,910 M
Pt 22 M 52 Sri Lanka III/B - 5163 M
Pt 23 F 60 South Africa IV/C - 254,437 S
Pt 24 F 40 Ireland III/B - 81,934 M
Pt 25 M 68 Australia III/B DM-II 3598 S
Pt 26 M 33 Australia III/B S 101,611 M
Pt 27 M 66 Australia III/B DM-II 138.5 M

Pt: patient; sex: M: male/F: female; S: smoking; DM-II: type II diabetes mellitus; status: S: single/M: married.

Table 2.

Presence of A. actinomycetemcomitans based on sociodemographic and other variables.

Variable Aa Test DF p-Value
Present N (%) Absent N (%)
Age ≤40 years old
>40 years old
9 (33.3)
18 (66.7)
27 (20.9)
102 (79.1)
1.935 1 0.164
Gender Male
Female
16 (59.3)
11 (40.7)
57 (44.2)
72 (55.8)
2.037 1 0.153
Origin Australian
Non-Australian
10 (37.0)
17 (63.0)
63 (48.8)
66 (51.2)
1.249 1 0.264
Smoking Smoker
Non-smoker
3 (11.1)
24 (88.9)
17 (13.2)
112 (86.8)
0.085 1 0.770

N: number; %: percentage; DF: degree of freedom.

3.2. Sociodemographic Data

One hundred and fifty-six patients were included in the present study. Of these, 83 (53.2%) were females and 73 (46.8%) were males. The age ranged between 26 and 86, with a mean of 54.03 years ± 12.13 S.D (standard deviation). Of the patients, 83 were of non-Australian origin or were born overseas (53.2%). A total of 106 of the patients were married (67.9%). A total of 100 (64.1%) patients were from Perth city, with the remaining 56 (35.9%) residing outside Perth city. In total, 120 of the patients were older than 40 years old (76.9%) (Table 3). The chi square test showed no statistically significant association between gender and level of education, marital status, and occupation. The chi square test also showed no statistical significance between marital status and level of education (Table 4).

Table 3.

Study population characteristics.

Characteristics Mean ± SD/N
Patient’s number 156
Age (years) 54.03 ± 12.13
Younger/Older (more than 40 years old) (36/120)
Gender (male/female) 73/83
A. actinomycetemcomitans (positive/negative) 27/129
Origin (Australian/overseas) 73/83
Marital status (single/married) 50/106
Residence (Perth/rural) 100/56

N: number; SD: standard deviation.

Table 4.

The relationship between sociodemographic characteristics and gender/marital status.

Variable Gender
X2 p-Value
Male
N (%)
Female
N (%)
Education Low 64 (87.7) 74 (89.2) 0.08 0.77
High 9 (12.3) 9 (10.8)
Marital status Married 53 (72.6) 53 (63.9) 1.36 0.24
Single 20 (27.4) 30 (36.1)
Occupation Working 51 (69.9) 53 (63.9) 0.63 0.42
Retired 22 (30.1) 30 (36.1)
Marital status
Married
N (%)
Single
N (%)
Education Low 91 (85.8) 47 (94) 2.21 0.13
High 15 (14.2) 3 (6)

N: number; %: percentage.

3.3. Tooth Loss Data

Two males (2.7%) had no tooth loss, and another thirty-one males (42.5%) had lost four teeth or less compared to forty males (54.8%) who lost five or more teeth. Periodontitis was the reason for tooth loss in 42.5% of the males. Three females (3.6%) had no tooth loss, and thirty-eight females (45.8%) who had lost four teeth or less compared to forty-two (50.6%) who had lost five teeth or more. Periodontitis was the reason for tooth loss in 44.6% of the females.

A total of fourteen (38.9%) of this age group lost their teeth due to periodontitis compared to twenty-two (61.1%) who lost their teeth due to other causes. Two patients (5.6%) of this group had no tooth loss compared to twenty-eight (77.8%) and six patients (16.7%) who lost four or less teeth and five or more teeth, respectively. In the older age group, fifty-four patients (45%) lost their teeth due to periodontitis. Of this age group, three patients (2.5%) had no tooth loss, forty-one (34.2%) lost four or less teeth, and seventy-six (63.3%) lost five or more teeth.

3.4. Potential Risk Factors for Periodontitis

On assessment of the known risks factors for periodontitis, 15 of the patients (9.6%) gave a medical history of managed systemic illnesses and treatment (such as diabetes mellitus type II, osteoporosis, and cancer therapy). Twenty of the patients (12.8%) were smokers.

A total of 118 of the patients (75.6%) were regular attenders at their general dentist for regular check-up and dental hygienist appointments compared to 38 patients who would only visit the dentist if they have issues like dental pain (24.4%). In total, 65.4% of the patients (n = 102) had good oral hygiene, with daily toothbrushing and flossing, compared to 34.6% of the patients (n = 54), who only brush their teeth. In Table 5, oral hygiene method (toothbrushing alone versus toothbrushing and flossing) is reported in relation to sociodemographic variables. Using a chi square test, there was a statistically significant difference between oral hygiene methods and gender, with more female patients both toothbrushing and flossing compared to male patients (X2 = 5.154, p = 0.02). There was a statistically significant difference between oral hygiene method and visits to the dentist, meaning that patients using combined toothbrushing and flossing were the ones who had high attendance at their general dentist appointments (X2 = 66.78, p ≤ 0.001). Non-smokers used the combined toothbrushing and flossing methods to look after their gum health significantly more often than smokers (X2 = 9.35, p = 0.004). There was no statistically significant difference between oral hygiene methods and the level of education and marital status.

Table 5.

Oral hygiene methods in relation to sociodemographic and other variables.

Variables Oral Hygiene Method X2 p-Value
Toothbrushing only N (%) Toothbrushing and Flossing N (%)
Gender Male 32 (59.3) 41 (40.2) 5.15 0.02
Female 22 (40.7) 61 (59.8)
Education Low 50 (92.6) 88 (86.3) 1.38 0.24
High 4 (7.4) 14 (13.7)
Marital status Married 33 (61.1) 73 (71.6) 1.77 0.18
Single 21 (38.9) 29 (28.4)
Dental visits Yes 20 (37) 98 (96.1) 66.79 <0.001
No 34 (63) 4 (3.9)
Smoking Yes 13 (24.1) 6.9 (20) 9.35 0.004
No 41 (75.9) 95 (93.1)

N: number; %: percentage.

A total of 84 of the patients had a family history of periodontitis (53.8%), compared to 60 patients (38.5%) who reported no family history of periodontitis, while 12 patients (7.7%) did not know of any family history of periodontitis (2 patients were adopted).

3.5. Clinical Outcomes

Table 6 reveals the distribution of the mean, standard deviation, and percentages of PD, CAL, BoP, PI, suppuration presence, bone loss/age, presence of bone loss, and presence of vertical bone loss according to gender, age, and A. actinomycetemcomitans presence. The results reveal that females have a higher value than males in terms of mean PD and CAL and that high mean values are more common in younger patients. Both PI and BoP scores were higher for men than women, while bone loss scores were higher for women than men.

Table 6.

Summary of the distribution of categorial variables for periodontal parameters related to gender, age, and presence of A. actinomycetemcomitans presence.

Variables Mean PD PD ≤ 4 mm (%) PD = 5 (%) PD ≤ 6
(%)
Mean CAL CAL 1–2
(%)
CAL 3–4
(%)
CAL ≥ 5
(%)
BoP
(%)
PI
(%)
Pus
(%)
BL/Age > 1
(%)
BL > 33
(%)
V-BL
(%)
Sex M 5.13 (1.97) 42.6 13.2 44.2 5.55 (1.85) 3.9 25.4 70.7 52.6 57.1 3.5 44.6 46.1 24.2
F 5.30 (2.12) 39.5 12.9 47.6 5.62 (2.05) 4.8 27.9 67.3 46 48.3 5.5 58.3 61 45
Age ≤40 Yrs 5.36 (2.11) 37.6 13.3 49.1 5.71 (1.99) 4.6 25.2 70.3 50.6 54.3 4.5 50.7 52.9 38
>40 Yrs 5.14 (2.39) 42.8 13 44 5.51 (1.95) 4.7 27.7 67.6 48 51.2 4.4 47.9 54.9 34.4
Aa Present 5.29 (1.98) 37.4 11.9 50.7 5.60 (1.95) 5.2 25.0 69.8 48.4 51.6 6.9 51.6 48.6 36.9
Absence 5.20 (2.07) 41.8 13.4 44.8 5.57 (1.97) 4.3 27.4 68.3 49.2 52.5 4.2 52 54.5 35

%: percentage; ±SD: standard deviation; M: male; F: female; PD: pocket depth; CAL: clinical attachment loss; BoP: bleeding upon probing; PI: plaque index; Yrs: years; BL: bone loss; V-BL: vertical bone loss.

3.6. Relationship between Periodontitis and Potential Risk Factors

Regarding the disease staging, 118 of the patients (75.6%) had stage-III periodontitis, whereas 35 (22.4%) had stage-IV periodontitis. Regarding the disease grade, 114 (73.1%) of the patients had grade-B periodontitis compared to 42 (26.9) of the patients who had grade-C periodontitis. In terms of disease extent, 130 patients (83.3%) had a generalized disease. As Table 7 shows, an association was found between the severity of periodontitis and oral hygiene protocol. The patients who only brushed their teeth had more risk of developing an advanced form of periodontitis compared to those who used both toothbrushing and flossing (X2 = 10.15, p = 0.006). Also, another relationship between periodontitis and irregular attendance at dental appointments was found, with the more advanced form of periodontitis associated with those who only attend dental practices for emergency dental treatment (X2 = 14.78, p ≤ 0.001).

Table 7.

Periodontitis and potential risk factors.

Variables Periodontitis
Stage-II N (%) Stage-III N (%) Stage-IV N (%) Test DF p-Value
Age ≤40 years old 1 (2.8) 22 (61.1) 13 (36.1) X2 = 5.38 2 0.068
>40 years old 2 (1.7) 96 (80) 22 (18.3)
Gender Male 2 (2.7) 57 (78.1) 14 (19.2) X2 = 1.23 2 0.540
Female 1 (1.2) 61 (73.5) 21 (25.3)
Smoking Non-smoker 2 (1.5) 106 (77.9) 28 (20.6) X2 = 3.48 2 0.175
Smoker 1 (5) 12 (60) 7 (35)
Oral Hygiene Toothbrushing only 1 (1.9) 33 (61.1) 20 (37) X2 = 10.15 2 0.006
Toothbrushing + flossing 2 (2) 85 (83.3) 15 (14.7)
Systemic diseases Yes 1 (6.7) 11 (73.3) 3 (20) X2 = 1.99 2 0.368
No 2 (1.4) 107 (75.9) 32 (22.7)
Dental visits Irregular 1 (2.6) 20 (52.6) 17 (44.7) X2 = 14.78 2 <0.001
Regular 2 (1.7) 98 (83.1) 18 (15.3)
Marital status Single 2 (4) 36 (72) 12 (24) X2 = 1.86 2 0.39
Married 1 (0.9) 82 (77.4) 23 (21.7)

N: number; %: percentage.

The results of the binary logistic regression (with a probability for entry = 0.05 and for removal = 0.10), including variables with a potential relation to the presence of severe forms of periodontitis, are presented in Table 8. The Omnibus Tests of Model Coefficients are significant. This shows that there is a significant improvement in fit, as compared to the null model; hence, the model shows a good fit (p = 0.024). In other words, the model describes the included data very well. The Hosmer and Lemeshow Test is also a test for model fit. This statistical test indicates a poor fit if the significance value is less than 0.05. Here, the model adequately fits the data. Hence, there is no difference between the observed and predicted models (p = 0.579).

Table 8.

Results of the binary logistic regression analysis.

Variable 95% CI for OR
B S.E. Wald p OR LL UL
Family history of periodontitis −0.799 0.372 4.624 0.032 0.450 0.217 0.932
Dental visit attendance 1.406 0.715 3.870 0.049 4.079 1.005 16.552

B: estimates for the slope coefficients of the univariate logistic regression model containing only this variable; S.E: estimated standard error for the estimated coefficient; p: value associated with the statistical coefficient test; OR: estimated odds ratio; CI: confidence interval of 95% for odds ratio; LL: lower limit; UL: upper limit.

An odds ratio was obtained for the following variables: family history of periodontitis B = −0.79, OR = 0.45, meaning that the patients with a history of periodontitis had double the risk of having a severe form of periodontitis compared to those with no family history of periodontitis. For the variable dental visit attendance, B = 1.40, OR = 4.07, meaning that the patients who were irregular attenders at their dental appointments were four times more likely to have an advanced form of periodontitis.

4. Discussion

A. actinomycetemcomitans is associated with periodontitis and systemic diseases, such as infective endocarditis, bacteremia, meningitis, and skin infection [20]. In the present work, the A. actinomycetemcomitans prevalence was 17.30%. The prevalence of A. actinomycetemcomitans is high in Asian and African populations but is significantly lower in Europe [21,22,23,24,25]. Our results are comparable to previous findings in an European population [26,27,28]. In one study in Finland, A. actinomycetemcomitans was positive in 13% of the population [25]. The prevalence in Switzerland and Italy was found to be 20% and 16%, respectively [29,30]. This relatively low representation of A. actinomycetemcomitans may be a representation of the European settlements in Western Australia.

Our data showed more risk of severe periodontitis with age, especially with young females. This is in contrast with other studies that showed an increase in the severity of periodontitis in elderly males [31,32,33,34]. However, those studies used a half mouth recording periodontal protocol, which can contribute to disease underestimation and inaccuracy. Our data revealed that the prevalence of stage-III periodontitis was 75.6% and great in older men, while the prevalence of stage-IV periodontitis was 22.4% and greater in younger women. A study by Relvas and co-authors found that the prevalence of stage-III periodontitis was 51.2% and greater in older males, while stage-IV periodontitis was 30.4% and again greater in older males [34]. Regarding the extent of periodontitis in our study, there was a higher prevalence of the generalized form (83.3%), which is in agreement with other studies [31,32,33,34]. It is worth mentioning that our study is the only one that has revealed an incisor–molar pattern of periodontitis extension using the 2018 classification [13].

Regarding clinical variables, the mean PD and CAL were higher in females compared to males and higher in the younger age group compared to the older age group. These figures were in line with other studies, but these averages were higher in our study. One reason is that the full mouth examination periodontal protocol that we used likely limited underestimation of the disease and contributed to more accuracy [33,34,35].

The subjects with an oral hygiene routine consisting of toothbrushing only and no flossing (X2 = 10.15, p = 0.006), and those who only attended dental appointments for emergencies (X2 = 14.78, p ≤ 0.001, B = −1.406, OR = 4.07) were found to be at a high risk of having severe periodontitis. The same apply to the patients with a familial history of periodontitis (B = −0.79, OR = 0.45).

Our study has a number of strengths and weakness, like any other study. We are the first study to explore the presence of A. actinomycetemcomitans in a cohort of Western Australia. We are also the first study to calculate the grading of periodontitis according to the 2018 classification. In our study, 114 (73.1%) of the patients had grade-B periodontitis compared to 42 (26.9%) of the patients having grade-C periodontitis. Missing teeth due to periodontal disease is a very vital piece of information and can be used to identify the stages of periodontitis. In our study, more teeth were lost to periodontitis in stage-III periodontitis cases than any other stages. One explanation for this could be due to the large number of patients in this group.

The downsides of our study are the lack of control groups (healthy periodontia), the inability to detect a cause–effect relationship, and the inability to guarantee results representation due to the snapshot nature. All patients were referred to a periodontal practice, so most of them were periodontally unstable. The convenience sampling method utilized indicates that periodontitis experience in the participants was more likely to be higher than in a randomly selected study population.

5. Conclusions

This study revealed a relatively low presence of A. actinomycetemcomitans in a cohort of Western Australia. The patients with a family history of periodontitis had double the risk of having a severe form of periodontitis compared to those with no family history of periodontitis. In addition, the patients who were irregular attenders at their dental appointments were four times more likely to have an advanced form of periodontitis compared to regular attenders. Poor oral hygiene was also identified as a potential risk factor for periodontitis in this cohort.

Author Contributions

All authors have made substantial contributions to the conception and design of the study. N.K., O.K., D.H. and L.A.M. were responsible for the study concept and design. N.K., A.J., A.A., J.O. and Z.R. were involved in the data collection and data analysis. The DNA isolation and qPCR analyses were carried out by A.A., J.O., N.K. and Z.R. All authors were involved in the data interpretation, drafting of the manuscript, and its critical revision. All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

Approval to conduct the current study was given by the Human Ethics, Office of Research at The University of Western Australia (2022/ET000252).

Informed Consent Statement

Written informed consent was obtained from the study participants.

Data Availability Statement

The data supporting this study’s findings are available by emailing the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

Funding Statement

This study was partly funded by TUA grants from Region Västerbotten, Sweden (to J.O.; 7003766, 7004758) and by an Erasmus Internship (to A.A.).

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

References

  • 1.Hajishengallis G. Interconnection of periodontal disease and comorbidities: Evidence, mechanisms, and implications. Periodontology 2000. 2022;89:9–18. doi: 10.1111/prd.12430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Baker J.L., Edlund A. Exploiting the Oral Microbiome to Prevent Tooth Decay: Has Evolution Already Provided the Best Tools? Front. Microbiol. 2018;9:3323. doi: 10.3389/fmicb.2018.03323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Henderson B., Ward J.M., Ready D. Aggregatibacter (Actinobacillus) actinomycetemcomitans: A triple A* periodontopathogen? Periodontology 2000. 2010;54:78–105. doi: 10.1111/j.1600-0757.2009.00331.x. [DOI] [PubMed] [Google Scholar]
  • 4.Johansson A. Aggregatibacter actinomycetemcomitans leukotoxin: A powerful tool with capacity to cause imbalance in the host inflammatory response. Toxins. 2011;3:242–259. doi: 10.3390/toxins3030242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Smith J.L., Bayles D.O. The contribution of cytolethal distending toxin to bacterial pathogenesis. Crit. Rev. Microbiol. 2006;32:227–248. doi: 10.1080/10408410601023557. [DOI] [PubMed] [Google Scholar]
  • 6.Zambon J.J. Actinobacillus actinomycetemcomitans in human periodontal disease. J. Clin. Periodontol. 1985;12:1–20. doi: 10.1111/j.1600-051X.1985.tb01348.x. [DOI] [PubMed] [Google Scholar]
  • 7.Das M., Badley A.D., Cockerill F.R., Steckelberg J.M., Wilson W.R. Infective endocarditis caused by HACEK microorganisms. Annu. Rev. Med. 1997;48:25–33. doi: 10.1146/annurev.med.48.1.25. [DOI] [PubMed] [Google Scholar]
  • 8.Mitsakakis K., Stumpf F., Strohmeier O., Klein V., Mark D., Von Stetten F., Peham J.R., Herz C., Tawakoli P.N., Wegehaupt F., et al. Chair/bedside diagnosis of oral and respiratory tract infections, and identification of antibiotic resistances for personalised monitoring and treatment. Stud. Health Technol. Inform. 2016;224:61–66. [PubMed] [Google Scholar]
  • 9.Nakao R., Hirayama S., Yamaguchi T., Senpuku H., Hasegawa H., Suzuki T., Akeda Y., Ohnishi M. A bivalent outer membrane vesicle-based intranasal vaccine to prevent infection of periodontopathic bacteria. Vaccine. 2023;41:4369–4383. doi: 10.1016/j.vaccine.2023.05.058. [DOI] [PubMed] [Google Scholar]
  • 10.Khzam N., Miranda L.A., Kujan O., Shearston K., Haubek D. Prevalence of the JP2 genotype of Aggregatibacter actinomycetemcomitans in the world population: A systematic review. Clin. Oral Investig. 2022;26:2317–2334. doi: 10.1007/s00784-021-04343-3. [DOI] [PubMed] [Google Scholar]
  • 11.Claesson R., Höglund-Åberg C., Haubek D., Johansson A. Age-related prevalence and characteristics of Aggregatibacter actinomycetemcomitans in periodontitis patients living in Sweden. J. Oral. Microbiol. 2017;9:1334504. doi: 10.1080/20002297.2017.1334504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Sanz M., van Winkelhoff A.J., Herrera D., Dellemijn-Kippuw N., Simón R., Winkel E. Differences in the composition of the subgingival microbiota of two periodontitis populations of different geographical origin. A comparison between Spain and The Netherlands. Eur. J. Oral. Sci. 2000;108:383–392. doi: 10.1034/j.1600-0722.2000.108005383.x. [DOI] [PubMed] [Google Scholar]
  • 13.Tonetti M.S., Greenwell H., Kornman K.S. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J. Periodontol. 2018;89((Suppl. S1)):S159–S172. doi: 10.1002/jper.18-0006. [DOI] [PubMed] [Google Scholar]
  • 14.Slade G.D., Spencer A.J., Roberts-Thomson K.F. Australia’s Dental Generations: The National Survey of Adult Oral Health 2004–06. Australian Institute of Health and Welfare; Canberra, Australia: 2007. Volume AIHW cat. no. DEN 165. [Google Scholar]
  • 15.Beck J.D., Koch G.G., Rozier R.G., Tudor G.E. Prevalence and risk indicators for periodontal attachment loss in a population of older community-dwelling blacks and whites. J. Periodontol. 1990;61:521–528. doi: 10.1902/jop.1990.61.8.521. [DOI] [PubMed] [Google Scholar]
  • 16.Brennan D., Luzzi L., Ellershaw A., Peres M. Australia’s Oral Health National Study of Adult Oral Health 2017–18. Australian Institute of Health and Welfare; Canberra, Australia: 2019. [Google Scholar]
  • 17.Ainamo J., Bay I. Problems and proposals for recording gingivitis and plaque. Int. Dent. J. 1975;25:229–235. [PubMed] [Google Scholar]
  • 18.Razooqi Z., Höglund Åberg C., Kwamin F., Claesson R., Haubek D., Oscarsson J., Johansson A. Aggregatibacter actinomycetemcomitans and Filifactor alocis as Associated with Periodontal Attachment Loss in a Cohort of Ghanaian Adolescents. Microorganisms. 2022;10:2511. doi: 10.3390/microorganisms10122511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Kirakodu S.S., Govindaswami M., Novak M.J., Ebersole J.L., Novak K.F. Optimizing qPCR for the Quantification of Periodontal Pathogens in a Complex Plaque Biofilm. Open Dent. J. 2008;2:49–55. doi: 10.2174/1874210600802010049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Nørskov-Lauritsen N., Claesson R., Jensen A.B., Åberg C.H., Haubek D. Aggregatibacter actinomycetemcomitans: Clinical significance of a pathobiont subjected to ample changes in classification and nomenclature. Pathogens. 2019;8:243. doi: 10.3390/pathogens8040243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Höglund Åberg C., Haubek D., Kwamin F., Johansson A., Claesson R. Leukotoxic activity of Aggregatibacter actinomycetemcomitans and periodontal attachment loss. PLoS ONE. 2014;9:e104095. doi: 10.1371/journal.pone.0104095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Haubek D., Ennibi O.K., Poulsen K., Vaeth M., Poulsen S., Kilian M. Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco: A prospective longitudinal cohort study. Lancet. 2008;371:237–242. doi: 10.1016/s0140-6736(08)60135-x. [DOI] [PubMed] [Google Scholar]
  • 23.Elamin A., Albandar J.M., Poulsen K., Ali R.W., Bakken V. Prevalence of Aggregatibacter actinomycetemcomitans in Sudanese patients with aggressive periodontitis: A case-control study. J. Periodontal Res. 2011;46:285–291. doi: 10.1111/j.1600-0765.2010.01337.x. [DOI] [PubMed] [Google Scholar]
  • 24.Macheleidt A., Müller H.P., Eger T., Putzker M., Fuhrmann A., Zöller L. Absence of an especially toxic clone among isolates of Actinobacillus actinomycetemcomitans recovered from army recruits. Clin. Oral Investig. 1999;3:161–167. doi: 10.1007/s007840050096. [DOI] [PubMed] [Google Scholar]
  • 25.Alaluusua S., Asikainen S. Detection and distribution of Actinobacillus actinomycetemcomitans in the primary dentition. J. Periodontol. 1988;59:504–507. doi: 10.1902/jop.1988.59.8.504. [DOI] [PubMed] [Google Scholar]
  • 26.Jensen A.B., Isidor F., Lund M., Væth M., Johansson A., Lauritsen N.N., Haubek D. Prevalence of Aggregatibacter actinomycetemcomitans and Periodontal Findings among 14 to 15-Year Old Danish Adolescents: A Descriptive Cross-Sectional Study. Pathogens. 2020;9:1054. doi: 10.3390/pathogens9121054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Hölttä P., Alaluusua S., Saarela M., Asikainen S. Isolation frequency and serotype distribution of mutans streptococci and Actinobacillus actinomycetemcomitans, and clinical periodontal status in Finnish and Vietnamese children. Scand. J. Dent. Res. 1994;102:113–119. doi: 10.1111/j.1600-0722.1994.tb01165.x. [DOI] [PubMed] [Google Scholar]
  • 28.Höglund Åberg C., Kwamin F., Claesson R., Dahlén G., Johansson A., Haubek D. Progression of attachment loss is strongly associated with presence of the JP2 genotype of Aggregatibacter actinomycetemcomitans: A prospective cohort study of a young adolescent population. J. Clin. Periodontol. 2014;41:232–241. doi: 10.1111/jcpe.12209. [DOI] [PubMed] [Google Scholar]
  • 29.Eick S., Pfister W. Comparison of microbial cultivation and a commercial PCR based method fordetection of periodontopathogenic species in subgingival plaque samples. J. Clin. Periodontol. 2002;29:638–644. doi: 10.1034/j.1600-051X.2002.290708.x. [DOI] [PubMed] [Google Scholar]
  • 30.Paolantonio M., di Bonaventura G., di Placido G., Tumini V., Catamo G., di Donato A., Piccolomini R. Prevalence of Actinobacillus actinomycetemcomitans and clinical conditions in children and adolescents from rural and urban areas of central Italy. J. Clin. Periodontol. 2000;27:549–557. doi: 10.1034/j.1600-051x.2000.027008549.x. [DOI] [PubMed] [Google Scholar]
  • 31.Jiao J., Jing W., Si Y., Feng X., Tai B., Hu D., Lin H., Wang B., Wang C., Zheng S., et al. The prevalence and severity of periodontal disease in Mainland China: Data from the Fourth National Oral Health Survey (2015–2016) J. Clin. Periodontol. 2021;48:168–179. doi: 10.1111/jcpe.13396. [DOI] [PubMed] [Google Scholar]
  • 32.Holtfreter B., Schwahn C., Biffar R., Kocher T. Epidemiology of periodontal diseases in the Study of Health in Pomerania. J. Clin. Periodontol. 2009;36:114–123. doi: 10.1111/j.1600-051X.2008.01361.x. [DOI] [PubMed] [Google Scholar]
  • 33.Ha D.H., John Spencer A., Ju X., Do L.G. Periodontal diseases in the Australian adult population. Aust. Dent. J. 2020;65((Suppl. S1)):S52–S58. doi: 10.1111/adj.12765. [DOI] [PubMed] [Google Scholar]
  • 34.Relvas M., López-Jarana P., Monteiro L., Pacheco J.J., Braga A.C., Salazar F. Study of Prevalence, Severity and Risk Factors of Periodontal Disease in a Portuguese Population. J. Clin. Med. 2022;11:3728. doi: 10.3390/jcm11133728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Sekino S., Takahashi R., Numabe Y., Okamoto H. Current status of periodontal disease in adults in Takahagi, Japan: A cross-sectional study. BMC Oral Health. 2020;20:60. doi: 10.1186/s12903-020-1046-4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data supporting this study’s findings are available by emailing the corresponding author.


Articles from Pathogens are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES